TLR2 and Sepsis: CEACAM1 is also reported to inhibit Toll-like Receptor-2 signaling and Toll-like Receptor-4, thus increased circulating soluble CEACAM1 might contribute to inhibition of Toll-like Receptor responses in sepsis [23,24].